SCHEMBL1831124

SCHEMBL1831124

CCCCNC(=O)/C=C/C(=O)OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZDHHC20 Q5W0Z9 3/20 0.56
ZDHHC2 Q9UIJ5 3/20 0.56
HCAR2 Q8TDS4 2/20 0.50
KEAP1 Q14145 1/20 0.50
NFE2L2 Q16236 1/20 0.50
GFPT1 Q06210 1/20 0.49
HPGD P15428 1/20 0.46
EPHX1 P07099 3/20 0.46
ACHE P22303 2/20 0.46
MAPT P10636 2/20 0.45
HTT P42858 1/20 0.45
ALDH1A1 P00352 1/20 0.45
RAB9A P51151 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HTR1A P08908 2/20 0.44
HTR2C P28335 2/20 0.44
HTR2A P28223 1/20 0.44
SLC6A4 P31645 1/20 0.44
HTR7 P34969 1/20 0.44
HTR6 P50406 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1831126 1.00 ZDHHC20 (0.56) ZDHHC20ZDHHC2HCAR2KEAP1NFE2L2
SCHEMBL1831127 1.00 ZDHHC20 (0.56) ZDHHC20ZDHHC2HCAR2KEAP1NFE2L2
SCHEMBL11529276 0.94 ZDHHC20 (0.63) ZDHHC20ZDHHC2HCAR2KEAP1NFE2L2
SCHEMBL11529282 0.94 ZDHHC20 (0.63) ZDHHC20ZDHHC2HCAR2KEAP1NFE2L2
SCHEMBL11529911 0.93 ZDHHC20 (0.66) ZDHHC20ZDHHC2HCAR2KEAP1NFE2L2
SCHEMBL11527610 0.93 ZDHHC20 (0.66) ZDHHC20ZDHHC2HCAR2KEAP1NFE2L2
SCHEMBL11529918 0.93 ZDHHC20 (0.66) ZDHHC20ZDHHC2HCAR2KEAP1NFE2L2
SCHEMBL11529036 0.93 ZDHHC20 (0.66) ZDHHC20ZDHHC2HCAR2KEAP1NFE2L2
SCHEMBL11530889 0.93 ZDHHC20 (0.66) ZDHHC20ZDHHC2HCAR2KEAP1NFE2L2
SCHEMBL11527605 0.93 ZDHHC20 (0.66) ZDHHC20ZDHHC2HCAR2KEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833870-B1 DURABLE COATING COMPOSITIONS CONTAINING NOVEL ASPARTIC AMINE COMPOUNDS DU PONT (US) 2011-05-11 EP disclosed
US-7682665-B2 Durable coating compositions containing novel aspartic amine compounds E.I. DU PONT DE NEMOURS AND COMPANY (US) 2010-03-23 US disclosed
US-7674499-B2 Durable coating compositions containing novel aspartic amine compounds E.I. DU PONT DE NEMOURS AND COMPANY (US) 2010-03-09 US disclosed
EP-1833870-A1 DURABLE COATING COMPOSITIONS CONTAINING NOVEL ASPARTIC AMINE COMPOUNDS E.I.Du pont de nemours and company (US) 2007-09-19 EP disclosed
US-7214828-B2 Durable coating compositions containing novel aspartic amine compounds E. I. DUPONT DE NEMOURS AND COMPANY (US) 2007-05-08 US disclosed
US-20060155053-A1 Durable coating compositions containing novel aspartic amine compounds AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) 2006-07-13 US disclosed
US-20060155054-A1 Durable coating compositions containing novel aspartic amine compounds AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) 2006-07-13 US disclosed
US-20060155148-A1 Durable coating compositions containing novel aspartic amine compounds AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) 2006-07-13 US disclosed
WO-2006066026-A1 DURABLE COATING COMPOSITIONS CONTAINING NOVEL ASPARTIC AMINE COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060155148-A1 Durable coating compositions containing novel aspartic amine compounds H1-0, H1-2, H1-5 ZDHHC20 4141/4885ZDHHC2 4421/4885HCAR2 859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.